96. クローン病
[臨床試験数:2,209,薬物数:1,276(DrugBank:240),標的遺伝子数:166,標的パスウェイ数:210

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03220841
(ClinicalTrials.gov)
October 9, 20176/7/2017Stricture Definition and Treatment (STRIDENT) Drug Therapy StudyStricture Definition and Treatment (STRIDENT) Drug Therapy StudyCrohn Disease;Inflammatory Bowel Diseases;Stricture; BowelDrug: Adalimumab Injection;Drug: Thiopurine;Procedure: Endoscopic balloon dilatationSt Vincent's Hospital MelbourneAustralasian Gastro Intestinal Research Foundation;AbbVieActive, not recruiting18 YearsN/AAll78Phase 4Australia
2EUCTR2016-003321-42-NL
(EUCTR)
18/01/201708/12/2016Stepwise extention of the adalimumab injection interval in patients with stable Crohn's disease.Lengthening Adalimumab Dosing Interval in quiescent Crohn’s disease patients: the LADI study. Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Trade Name: Humira (adalimumab)
Product Name: Adalimumab
INN or Proposed INN: ADALIMUMAB
Radboud University Medical CentreNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Phase 4Netherlands